source
- HHS launches funding programs to accelerate U.S. clinical trials amid rising Chinese competitionHHS announced new initiatives aimed at speeding up clinical trial development in the United States. The department introduced a five-year program called "Surpass" that seeks proposals from teams wi…
- Foghorn Therapeutics cuts 40% of workforce after ending Lilly oncology partnershipFoghorn Therapeutics and Eli Lilly announced the end of their 2021 oncology collaboration. The partnership had focused on developing and commercializing cancer treatments. Following the terminatio…